MJNA Stock UPDATES Medical Marijuana I (MJNA) 0.1560 08/19/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Medical Marijuana I (MJNA) 0.1560 $MJNA

Medical Marijuana Inc.'s HempMeds Featured in Groundbreaking Cable TV Documentary on Cannabidiol (CBD)
GlobeNewswire - Tue Aug 19, 8:00AM CDT
Medical Marijuana Inc. (OTC Pink:MJNA) is extremely proud to announce that its subsidiary company, HempMeds(TM), is being featured in a groundbreaking documentary on industrial hemp cannabidiol (CBD) by AWE TV.

Medical Marijuana Inc. & Wellness Managed Services' MPSI Featured by Bloomberg, Lands Exclusive Seattle Hempfest Security Contract
GlobeNewswire - Thu Aug 14, 8:06AM CDT
Medical Marijuana, Inc. (OTC Pink:MJNA) is pleased to announce that its subsidiary, Wellness Managed Services' MPS International (MPSI), was recently featured by Bloomberg and was selected to provide on-site event security services at SeattleHempfest August 15-17. Seattle Hempfest is the world's largest annual cannabis protest rally featuring six stages for music and speakers and more than 400 exhibits featuring food, arts and crafts. Admission is free and, at Seattle's 23 annual Hempfest, attendees will see a new feature: a legal recreational cannabis use area.

Looking to Invest in Unusual Businesses?
ACCESSWIRE - Thu Aug 14, 8:05AM CDT
Deerfield Beach, FL / Aug 14, 2014 / When investing in the stock market, investors generally look for companies that are in familiar businesses. Understanding a company's business model certainly makes analysis easier. However, beating the market with these stocks can generally be a challenge. That is why investors should also look at companies that are involved in unusual businesses. The main advantage of investing in such companies is that they do not face significant competition. This means that if their business model is sound they can generate significant returns and even beat the market on a consistent basis.

Organigram: The Next Publicly-Traded MMPR Licensed Producer
ACCESSWIRE - Mon Aug 11, 8:26AM CDT
WHITEFISH, MT / August 11, 2014 / The market for legalized medical marijuana in Canada is expected to generate $1.3 billion in annual revenue over the next ten years, driven by a rapidly expanding patient population under the country's new Marihuana for Medical Purposes Regulations ("MMPR" , which was introduced earlier this year to replace the old Medical Marihuana Access Program ("MMAR" regulations.

National Press Coverage for Medical Marijuana, Inc. -- Portfolio Company Kannalife Sciences Awarded NIH License to Develop Target Drugs to Treat Concussion Syndrome CTE Using Marijuana
GlobeNewswire - Tue Aug 05, 1:45PM CDT
Medical Marijuana, Inc. (OTC Pink: MJNA) is pleased to announce that one of its investment portfolio companies, KannaLife Sciences, Inc. ("KannaLife" , a bio-pharmaceutical and phyto-medical company, has been awarded its second license agreement by the National Institutes of Health (NIH) to develop a drug to treat a concussion syndrome called CTE using derivatives from medical marijuana. The license agreement is in effect through February, 2021. In addition to CTE, in June 2012, KannaLife was previously awarded an exclusive license from NIH, for the same '507 Patent, for the development of a target drug candidate for treating Hepatic Encephalopathy (HE).

NTRR: Cannabis Boom Continues as New Markets Open
Business Wire - Tue Aug 05, 4:41AM CDT
As Neutra Corp. (OTCBB: NTRR) prepares to begin manufacturing and distributing its subsidiary's groundbreaking new vapor pen product, demand for cannabis-related products has taken another jump as recreational sales begin in the state of Washington.

Flagship Financial Year for Cannabis Science (CBIS:OTC.QB) Arrives Amid New Medical Marijuana Legislation
ACCESSWIRE - Thu Jul 24, 7:34AM CDT
BOCA RATON, FL / ACCESSWIRE / July 24, 2014 / In the fast growing small cap market of medical marijuana companies we believe Cannabis Science stands out among its peers such as American Green (ERBB: OTC.PK), Medical Marijuana, Inc (MJNA:OTC.PK), Hemp, Inc (HEMP:OTC.PK) and Abattis Bioceuticals Corp (ATTBF:OTC.QX)

NTRR: Cannabis Demand in California Could Top $2.1 Trillion
Business Wire - Tue Jul 22, 5:46AM CDT
Even as the state of Washington became the second to begin allowing recreational cannabis sales last week, Neutra Corp. (OTCBB: NTRR) and other business ancillary to the cannabis marketplace are already eying the potential for even larger marketplaces to the south. SF Weekly reported last week that demand for recreational cannabis in California could top an astounding $2.1 trillion.

A New Audio Interview With Michael Julian, Managing Director of MPSI, is Now at SmallCapVoice.com
GlobeNewswire - Wed Jul 16, 7:23AM CDT
SmallCapVoice.com, Inc. (SCV) announced today that a new audio interview with Wellness Managed Services' MPS International (MPSI), a Medical Marijuana, Inc. (OTC Pink:MJNA) subsidiary, is now available. The interview can be heard at http://smallcapvoice.com/blog/7-11-14-smallca...a-inc-mjna.

New Markets Open up for NTRR Products
Business Wire - Thu Jul 10, 6:30AM CDT
As Neutra Corp. (OTCBB: NTRR) and its joint venture partners work to create innovative new indoor horticulture solutions, an enormous market for medical cannabis cultivation appears to be opening up in Canada.

Medical Marijuana Inc. Announces First Quarter 2014 Shareholders Report: Product Sales Increase More Than 100% Quarter Over Quarter
GlobeNewswire - Tue Jul 08, 8:23AM CDT
Medical Marijuana Inc. (OTC Pink: MJNA), a leading cannabis and industrial hemp industry innovator, today announced the release of its quarterly financial and shareholders report (Post 06/30/2014 - OTC Markets). The Company had product sales revenues of $4.01 million compared to $1.94 million for the prior quarter. Below are the Company's first quarter 2014 operating and developmental highlights.

NTRR Scouts Opportunities in Underserved Cannabis Financial Services Sector
Business Wire - Tue Jul 08, 4:00AM CDT
With cannabis sales spreading across the country thanks to growing legalization and regulation of the herb, Neutra Corp. (OTCBB: NTRR) is investigating new opportunities arising in the fledgling industry's financial services sector.

NTRR: Maturing Cannabis Marketplace Attracts Serious Business
Business Wire - Wed Jun 25, 4:00AM CDT
As Neutra Corp. (OTCBB: NTRR) prepares new products for the booming marketplace ancillary to the cannabis industry, that business sector continues to show encouraging signs of maturity. This week, the Colorado Convention Center and Crowne Plaza Hotel in Denver will host the National Cannabis Industry Association's (NCIA) inaugural Cannabis Business Summit, a traditional industry trade show for a fast-growing sector once considered highly untraditional.

Budding Marijuana Businesses to be Mentored by Medical Marijuana Inc. & Wellness Managed Services' MPSI at Las Vegas Expo
GlobeNewswire - Wed Jun 18, 9:17AM CDT
Medical Marijuana, Inc. (OTC Pink:MJNA) is pleased to announce that its subsidiary, Wellness Managed Services' MPS International (MPSI), is a sponsor of the inaugural International Cannabis Association "Green to Green" networking and educational conference at the Hard Rock Hotel & Casino June 22-23. During the conference, MPSI Managing Director and security industry veteran Michael Julian and others will mentor business professionals interested in establishing marijuana-related businesses. New York Senator and medical marijuana advocate Diane Savino is currently pushing for medical use policy reform in her state and is a keynote speaker at the 7:00 a.m. fundraiser breakfast on Monday, June 24.

Colorado's Growing Cannabis Sales Open New Opportunities for NTRR
Business Wire - Tue Jun 17, 8:02AM CDT
Impressive sales growth from Colorado's cannabis businesses has more states weighing potential legalization, potentially leading to large-scale market growth for support-industry companies including Neutra Corp. (OTCBB: NTRR).

Medical Marijuana Inc.'s HempMeds Makes Global News Headlines and Report Issued by Top Laboratory
GlobeNewswire - Thu Jun 12, 2:37PM CDT
Medical Marijuana, Inc. (OTC Pink:MJNA) is excited to announce that its subsidiary HempMeds(TM) and the cannabidiol (CBD)-rich hemp oil that the company represents, markets and distributes are making positive news headlines around the world after participating in the Chicago Cannabis Conference hosted by MyCompassion.org, a 501(c)3 non-profit organization. These innovative CBD-rich hemp oil products have been reviewed by top laboratories in the cannabis industry. The latest test results and certificates of analysis (COA) can be found at: http://hempmedspx.com/wp-content/uploads/2013...84_LAB.pdf

OTC Sector Trading Focus List: Green Cures & Botanical Distribution, Hemp, Inc. GreenGro Technologies, Cannabis Science, Inc. Medical Marijuana, Inc.
PR Newswire Europe - Wed Jun 11, 5:03AM CDT
LONDON, May 30, 2014 /PRNewswire/ --

Photo Release -- Medical Marijuana Inc.'s HempMeds Covered in Global Media at Chicago Cannabis Conference
GlobeNewswire - Tue Jun 10, 8:14AM CDT
Medical Marijuana Inc. (OTC Pink:MJNA) is pleased to announce that its subsidiary company, HempMeds(TM), was the platinum sponsor of the Chicago Cannabis Conference in Chicago, Illinois June 7-8. The Chicago Cannabis Conference was hosted by MyCompassion, a non-profit organization whose mission is to educate the public on medical cannabis use with the passing of the Illinois Compassionate Care Act. Billboards conveying the upcoming conference were strategically placed throughout the Chicago Metro area reaching millions of impressions leading up to the event that was held at Navy Pier at the conclusion of Hemp History Week.

Medical Marijuana Inc.'s HempMedsPX Joins Medical Cannabis Network
GlobeNewswire - Wed Apr 02, 8:43AM CDT
Medical Marijuana Inc.'s (OTC Pink:MJNA) HempMedsPX(TM) - a corporate portfolio company of Medical Marijuana Inc. and the exclusive master distributor and contracted marketing company for Medical Marijuana, Inc. and its portfolio of companies - has finalized a strategic marketing partnership with Medical Cannabis Network (MCN). MCN will directly market HempMedsPX(TM) through its MarijuanaDoctors.com and PotLocator.com brands. The online following of these MCN brands includes more than 6,000 dispensaries, 100,000 opt-in newsletter subscribers, 148,000 "Likes" on Facebook, and 35,000 followers on Twitter. The immediate benefit to Medical Marijuana Inc. is an increase in consumer awareness and an increase in the visibility of the cannabidiol (CBD)-rich hemp oil products that HempMedsPX(TM) represents.

Photo Release -- Medical Marijuana Inc.'s HempMedsPX Launches DON'T MOVE Awareness Campaign
GlobeNewswire - Tue Apr 01, 8:25AM CDT
Medical Marijuana Inc. (OTC Pink:MJNA) is pleased to announce that its subsidiary company and contracted marketing agent, HempMedsPX(TM), is launching a public awareness campaign--"DON'T MOVE"-- to counter recent reports by the mainstream media that one must relocate to a legalized medical marijuana state to access cannabidiol (CBD) oil. Through "DON'T MOVE", HempMedsPX(TM) is expanding its current public awareness campaign that CBD-rich hemp oil is openly available in all 50 states and more than 40 countries. The Company plans to officially launch the "DON'T MOVE" campaign in April at all of the industry conferences, expos and events they are attending or sponsoring.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 121

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 173

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 211

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 210

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
CCAPP Holiday Training Targets Seasonal Recovery Strain

Updated Category News Views 126

December cheer has a nasty habit of hiding the people barely holding themselves together. CCAPP’s upcoming virtual workshop, Hope for the Holidays: Understanding Depression, Stress & Resilience During the Holiday Season, takes that uncomfortable reality seriously rather than treating it like a seasonal footnote. For behavioral health workers supporting people in...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 123

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 175

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 95

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 157

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
QuidelOrtho Faces Fresh Scrutiny Over Savanna Claims

Updated Category News Views 203

A diagnostic launch can turn into a corporate migraine with frightening speed, and QuidelOrtho is staring at exactly that sort of mess. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether QuidelOrtho officers or directors breached fiduciary duties or otherwise violated state or federal law. This is not a finding of wrongdoing. It is an...

Continue Reading

Top 5 Most Recently Viewed Articles

dbt Labs Transforms Data Management with MetricFlow Open Source

Updated Category News Views 735

Embracing Open Source with MetricFlow In a groundbreaking move, dbt Labs recently announced its commitment to advancing trustworthy AI by open sourcing MetricFlow. This initiative represents a significant turning point in how organizations manage and utilize data in the era of artificial intelligence. The shift to an Apache 2.0 license not only safeguards the integrity of...

Continue Reading
EssilorLuxottica Achieves Euro 2 Billion Bond Issuance Success

Updated Category News Views 117

EssilorLuxottica's Successful Bond Issuance EssilorLuxottica has reached a noteworthy milestone by successfully issuing a Euro 2 billion bond at an attractive average rate of 2.99%. This strategic financial move highlights the company's strong position in the market and its appeal to investors. Details of the Bond Issuance The bond issuance features tenors of 4.5 years...

Continue Reading
Streamlined Home Selling Solutions Introduced in North Carolina

Updated Category News Views 292

Revolutionizing Home Selling in North Carolina Fair Cash Offers For Homes has recently launched its innovative service, ‘Sell Your House Fast North Carolina,’ designed to facilitate quick and efficient sales for homeowners. With the ever-changing real estate landscape, many individuals find themselves needing to sell their properties under various circumstances,...

Continue Reading
Ipsen Employee Admits to Insider Trading on Cancer Drug Deal

Updated Category News Views 268

Guilty Plea Tied to a Drugmaker’s Takeover Plans An employee at the French pharmaceutical company Ipsen has agreed to plead guilty to insider trading. The case, centered on trading ahead of a proposed acquisition, underscores the stakes around confidentiality in drug development and the pressures that test corporate governance. What Prosecutors Allege Dishant Gupta,...

Continue Reading
Oscar Health Achieves 52-Week Record with $23.45 Stock Price

Updated Category News Views 221

Oscar Health Achieves New Stock Performance Highs In a striking example of market resilience, Oscar Health, Inc. (OSCR) has reached an impressive 52-week high with its stock hitting $23.45. This achievement signifies a remarkable growth phase for the company, which has experienced an incredible one-year change of 288.51%. Investors have shown strong support for Oscar...

Continue Reading